Research in the United States on the AstraZeneca vaccine, declared effective for adults

 


Pharmaceutical company AstraZeneca says that, The use of its vaccine against coronavirus has established a strong defense system against the disease in adults.


 

  According to the Associated Press (AP), the research study will restore public confidence in the company's vaccine, and the findings are an important step toward approving the vaccine's use in the United States.

The vaccine given to 3,000 people during the study was 79% effective. Older people were also included in the study. None of the people who volunteered in the research experiments had a serious illness or hospitalization, compared to five when the people were given a dummy vaccine. Had fallen

Safety Concerns: Many European Countries Stop Using AstraZeneca Vaccine

The AstraZeneca company has said that its independent testing of the vaccine's safety did not reveal any side effects. The study found that there were no reports of blood clots from the vaccine in Europe.

It should be noted that the use of this vaccine was stopped in many countries in Europe after reports of blood clots.

Mini Pangalos, the company's top researcher, told the Associated Press that it was hoped that research in the United States would clear up any doubts about the vaccine's effectiveness. And now the vaccine will be used in other parts of the world.

Popular posts from this blog

Katrina Kaif pays tribute to renowned artist

Agreement between PITB and Chirp Technologies to make Lahore a smart city

Pakistan will not provide any base to US: PM Imran Khan

Mud volcano in Balochistan